Stay updated on MRTX849 Combo vs Chemotherapy in KRAS G12C Clinical Trial
Sign up to get notified when there's something new on the MRTX849 Combo vs Chemotherapy in KRAS G12C Clinical Trial page.

Latest updates to the MRTX849 Combo vs Chemotherapy in KRAS G12C Clinical Trial page
- Check6 days agoChange DetectedThe footer now displays Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed, replacing the previous Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page footer revision was updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedNew revision label v3.3.1 was added and the previous label v3.2.0 was removed from the page's history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRemoved a site-wide notice about government funding delays and potential interruptions that warned information may not be up to date.SummaryDifference0.4%

- Check56 days agoChange DetectedNew entries were added to the record history, reflecting recent updates with additional version dates. The core study details and statuses appear unchanged.SummaryDifference0.1%

- Check84 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference9%

Stay in the know with updates to MRTX849 Combo vs Chemotherapy in KRAS G12C Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRTX849 Combo vs Chemotherapy in KRAS G12C Clinical Trial page.